Search
01/10/2021
Electronic health records and patient registries in medical oncology departments in Spain
Ribelles, N, Alvarez-Lopez, I, Arcusa, A, Chacon, JI, de la Haba, J, Garcia-Corbacho, J, Garcia-Mata, J, Jara, C, Jerez, JM, Lazaro-Quintela, M, Leon-Mateos, L, Ramirez-Merino, N, Tibau, A, Garcia-Palomo, A. Electronic health records and patient registries in medical oncology departments in Spain. Clinical & Translational Oncology. 2021; 23(10)DOI:10.1007/s12094-021-02614-9. PMID:33864619. IF:3.340(Q3/7D).
01/10/2021
Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations
Riudavets, M, Sullivan, I, Abdayem, P, Planchard, D. Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations. ESMO Open. 2021; 6(5)DOI:10.1016/j.esmoop.2021.100260. PMID:34479034. IF:6.883(Q1/3D).
01/10/2021
Prognostic capacity of the weighted lymph node ratio in head and neck squamous cell carcinoma patients treated with salvage neck dissection
Neumann, ED, Sansa, A, Casasayas, M, Gutierrez, A, Quer, M, Leon, X. Prognostic capacity of the weighted lymph node ratio in head and neck squamous cell carcinoma patients treated with salvage neck dissection. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2021; 278(10)DOI:10.1007/s00405-020-06598-0. PMID:33452917. IF:3.236(Q2/3D).
01/10/2021
COVID-19 Pandemic and its Impact on the Management of Head and Neck Cancer in the Spanish Healthcare System
Mayo-Yanez, M, Palacios-Garcia, JM, Calvo-Henriquez, C, Ayad, T, Saydy, N, Leon, X, Parente, P, Chiesa-Estomba, CM, Lechien, JR. COVID-19 Pandemic and its Impact on the Management of Head and Neck Cancer in the Spanish Healthcare System. International Archives Of Otorhinolaryngology. 2021; 25(04)DOI:10.1055/s-0041-1736425. PMID:34777593. IF:(Q/D).
01/10/2021
The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
Einsele, H, Briones, J, Ciceri, F, Cadenas, IG, Falkenburg, F, Bolanos, N, Heemskerk, HMM, Houot, R, Hudecek, M, Locatelli, F, Morgan, K, Morris, EC, O'Dwyer, M, Sierra, JG, van den Brink, M, van de Loosdrecht, AA. The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies. Hemasphere. 2021; 5(10)DOI:10.1097/HS9.0000000000000642. PMID:34522844. IF:8.300(Q1/2D).
01/10/2021
Adverse prognostic impact of complex karyotype (>= 3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)
Genesca, E, Morgades, M, Gonzalez-Gil, C, Fuster-Tormo, F, Haferlach, C, Meggendorfer, M, Montesinos, P, Barba, P, Gil, C, Coll, R, Moreno, MJ, Martinez-Carballeira, D, Garcia-Cadenas, I, Vives, S, Ribera, J, Gonzalez-Campos, J, Diaz-Beya, M, Mercadal, S, Artola, MT, Cladera, A, Tormo, M, Bermudez, A, Vall-llovera, F, Martinez-Sanchez, P, Amigo, ML, Monsalvo, S, Novo, A, Cervera, M, Garcia-Guinon, A, Ciudad, J, Cervera, J, Hernandez-Rivas, JM, Granada, I, Haferlach, T, Orfao, A, Sole, F, Ribera, JM. Adverse prognostic impact of complex karyotype (>= 3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL). LEUKEMIA RESEARCH. 2021; 109DOI:10.1016/j.leukres.2021.106612. PMID:34139642. IF:3.715(Q3/6D).
01/10/2021
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain
Ribera, JM, Morgades, M, Coll, R, Barba, P, Lopez-Lorenzo, JL, Montesinos, P, Foncillas, MA, Cabrero, M, Gomez-Centurion, I, Morales, MD, Varela, MR, Herrera, P, Garcia-Cadenas, I, Calbacho, M, Torrent, A, Maluquer, C, Calabuig, M, Garcia-Guinon, A, Bautista, G, Llorente, L, Gil, C, Artola, MT, Gonzalez-Campos, J, Fernandez-Moreno, A, Barez, A, Gimenez-Perez, T, Bergua, J, Sanchez-Sanchez, MJ, Mateos, MC, Pinana, JL. Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain. Clinical Lymphoma Myeloma & Leukemia. 2021; 21(10)DOI:10.1016/j.clml.2021.06.024. PMID:34376375. IF:2.822(Q3/8D).
01/10/2021
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials
Ribera, JM, Morgades, M, Genesca, E, Chapchap, EC, Montesinos, P, Acuna-Cruz, E, Gil, C, Garcia-Cadenas, I, Barba, P, Gonzalez-Campos, J, de Llano, MPQ, Torrent, A, Ribera, J, Granada, I, Bernal, T, Diaz-Beya, M, Amigo, ML, Coll, R, Tormo, M, Vall-llovera, F, Gomez-Centurion, I, Sanchez-Sanchez, MJ, Soria, B, Cladera, A, Artola, MT, Garcia-Guinon, A, Gimenez-Conca, A, Amador, ML, Martinez-Sanchez, P, Algarra, JL, Vidal, MJ, Alonso, N, Maluquer, C, Llorente, L, Garcia-Boyero, R, Ciudad, J, Feliu, E, Orfao, A. Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials. HEMATOLOGICAL ONCOLOGY. 2021; 39(4)DOI:10.1002/hon.2910. PMID:34405901. IF:4.850(Q2/5D).